low molecular weight heparin

(redirected from Fraxiparine)

low mo·lec·u·lar weight hep·a·rin

(LMWH) (lō mŏ-lek'yŭ-lăr wāt hep'ăr-in)
A form of heparin with a longer half life and fewer adverse effects (e.g., thrombocytopenia).

low molecular weight heparin

Abbreviation: LMWH
The most bioavailable fraction of heparin. It has a more precise anticoagulant effect than unfractionated heparins and is used to prevent and treat deep venous thrombosis, pulmonary embolism, and acute coronary syndromes.

CAUTION!

It should be used selectively, if at all, in patients with reduced kidney function.
See also: heparin
References in periodicals archive ?
Contract award notice: "supply of fentanyl-richter 50 micrograms / ml (fentanyl) and fraxiparine 3800 iu anti-factor xa / 0.
ASPEN CLOSES BUY OF ARIXTRA, FRAXIPARINE COMMERCIAL OPERATIONS
Backward integration: The Merck site manufactures, among other things, heparin, which is needed to produce another drug, Fraxiparine, which Aspen intends to acquire from GSK.
Efficacy and tolerance of fraxiparine in the prevention of deep vein thrombosis in general surgery performed with medullar conduction anesthesia.
Heparins and heparinoids (used in the treatment of thromboses): to sell all of its development, production and marketing activities relating to Fraxiparine and Arixtra at world level.
The group unveiled an agreement earlier this month with Sanofi-Synthelabo to buy injectable drugs Fraxiparine and Arixtra.
The group yesterday struck a deal with Sanofi-Synthelabo to buy injectable drugs Fraxiparine and Arixtra, which have combined annual sales of 343 million euros (pounds 225.
Heparin-induced thrombocytopenia: discrepancy between the presence of IgG cross-reacting in vitro with fraxiparine and its successful clinical use.
31 December 2013 - South Africa's Aspen Pharmacare Holdings Ltd (JNB:APN) said today it had completed the acquisition of the commercial activities related to UK drugmaker GlaxoSmithKline Plc's (LON:GSK) thrombosis brands Arixtra and Fraxiparine.
M2 EQUITYBITES-December 31, 2013-Aspen closes buy of Arixtra, Fraxiparine commercial operations
5m deal with Sanofi, which employs 500 people at a factory in Newcastle and 200 at a research and development facility in Alnwick, will see Glaxo acquire injectable drugs Fraxiparine and Arixtra, which have combined annual sales of u225.
GLAXO TO SELL ARIXTRA, FRAXIPARINE THROMBOSIS BRANDS TO ASPEN